The 3 analysts offering 12-month price forecasts for Medpace Holdings Inc have a median target of 145.00, with a high estimate of 149.00 and a low estimate of 142.00. The median estimate represents a -10.10% decrease from the last price of 161.29.
The current consensus among 5 polled investment analysts is to Hold stock in Medpace Holdings Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.47
Reporting Date Oct 25
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.